{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:06:07Z","timestamp":1749096367321,"version":"3.41.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,3]]},"DOI":"10.7759\/cureus.85312","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T06:12:16Z","timestamp":1749017536000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Assisted Reproductive Technology Outcomes Using Crossover Administration of Two Recombinant Follicle-Stimulating Hormones in the Same Patients"],"prefix":"10.7759","author":[{"given":"Shoji","family":"Kokeguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohyu","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Shiotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.09.069","article-title":"Comparing anti-M\u00fcllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function","volume":"91","author":"Barad DH","year":"2009","unstructured":"Barad DH, Weghofer A, Gleicher N. Comparing anti-M\u00fcllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril. 2009, 91:1553-5. 10.1016\/j.fertnstert.2008.09.069","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee TH","year":"2008","unstructured":"Lee TH, Liu CH, Huang CC, et al.. Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008, 23:160-7. 10.1093\/humrep\/dem254","journal-title":"Hum Reprod"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer SL","year":"2014","unstructured":"Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014, 20:688-701. 10.1093\/humupd\/dmu020","journal-title":"Hum Reprod Update"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.10.011","article-title":"Age-specific serum anti-M\u00fcllerian hormone values for 17,120 women presenting to fertility centers within the United States","volume":"95","author":"Seifer DB","year":"2011","unstructured":"Seifer DB, Baker VL, Leader B. Age-specific serum anti-M\u00fcllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011, 95:747-50. 10.1016\/j.fertnstert.2010.10.011","journal-title":"Fertil Steril"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12522-011-0097-2","article-title":"Gonadotropin stimulation: past, present and future","volume":"11","author":"Lunenfeld B","year":"2012","unstructured":"Lunenfeld B. Gonadotropin stimulation: past, present and future. Reprod Med Biol. 2012, 11:11-25. 10.1007\/s12522-011-0097-2","journal-title":"Reprod Med Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-199809030-00006","article-title":"Follitropin alpha in infertility: a review","volume":"9","author":"Goa KL","year":"1998","unstructured":"Goa KL, Wagstaff AJ. Follitropin alpha in infertility: a review. BioDrugs. 1998, 9:235-60. 10.2165\/00063030-199809030-00006","journal-title":"BioDrugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab155","article-title":"A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF\/ICSI patients","volume":"36","author":"Qiao J","year":"2021","unstructured":"Qiao J, Zhang Y, Liang X, et al.. A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF\/ICSI patients. Hum Reprod. 2021, 36:2452-62. 10.1093\/humrep\/deab155","journal-title":"Hum Reprod"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.992677","article-title":"Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)","volume":"13","author":"Blockeel C","year":"2022","unstructured":"Blockeel C, Griesinger G, Rago R, Larsson P, Sonderegger YL, Rivi\u00e8re S, Laven JS. Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study). Front Endocrinol (Lausanne). 2022, 13:10.3389\/fendo.2022.992677","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-016-0675-7","article-title":"IVF results in patients with very low serum AMH are significantly affected by chronological age","volume":"33","author":"Revelli A","year":"2016","unstructured":"Revelli A, Biasoni V, Gennarelli G, Canosa S, Dalmasso P, Benedetto C. IVF results in patients with very low serum AMH are significantly affected by chronological age. J Assist Reprod Genet. 2016, 33:603-9. 10.1007\/s10815-016-0675-7","journal-title":"J Assist Reprod Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.07.006","article-title":"Establishing the follitropin delta dose that provides a comparable ovarian response to 150\u00a0IU\/day follitropin alfa","volume":"41","author":"Arce JC","year":"2020","unstructured":"Arce JC, Larsson P, Garc\u00eda-Velasco JA. Establishing the follitropin delta dose that provides a comparable ovarian response to 150\u00a0IU\/day follitropin alfa. Reprod Biomed Online. 2020, 41:616-22. 10.1016\/j.rbmo.2020.07.006","journal-title":"Reprod Biomed Online"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1530\/RAF-23-0045","article-title":"Algorithm vs clinical experience: controlled ovarian stimulations with follitropin delta and individualised doses of follitropin alpha\/beta","volume":"5","author":"Gazzo I","year":"2024","unstructured":"Gazzo I, Bovis F, Colia D, Sozzi F, Costa M, Anserini P, Massarotti C. Algorithm vs clinical experience: controlled ovarian stimulations with follitropin delta and individualised doses of follitropin alpha\/beta. Reprod Fertil. 2024, 5:10.1530\/RAF-23-0045","journal-title":"Reprod Fertil"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfre.2020.12.002","article-title":"In\u00a0vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta","volume":"2","author":"Haakman O","year":"2021","unstructured":"Haakman O, Liang T, Murray K, et al.. In\u00a0vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta. F S Rep. 2021, 2:30-5. 10.1016\/j.xfre.2020.12.002","journal-title":"F S Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2023.12.011","article-title":"Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF\/ICSI procedures (DELTA Study)","volume":"293","author":"Porcu-Buisson G","year":"2024","unstructured":"Porcu-Buisson G, Maignien C, Swierkowski-Blanchard N, et al.. Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF\/ICSI procedures (DELTA Study). Eur J Obstet Gynecol Reprod Biol. 2024, 293:21-6. 10.1016\/j.ejogrb.2023.12.011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deae047","article-title":"Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles","volume":"39","author":"Vidal MD","year":"2024","unstructured":"Vidal MD, Mart\u00ednez F, Rodr\u00edguez I, Polyzos NP. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles. Hum Reprod. 2024, 39:1098-104. 10.1093\/humrep\/deae047","journal-title":"Hum Reprod"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01372-w","article-title":"Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization\/intracytoplasmic sperm injection cycles: a systematic review with meta-analysis","volume":"17","author":"Palomba S","year":"2024","unstructured":"Palomba S, Caserta D, Levi-Setti PE, Busnelli A. Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization\/intracytoplasmic sperm injection cycles: a systematic review with meta-analysis. J Ovarian Res. 2024, 17:10.1186\/s13048-024-01372-w","journal-title":"J Ovarian Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.328","article-title":"Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line","volume":"54","author":"Olsson H","year":"2014","unstructured":"Olsson H, Sandstr\u00f6m R, Grundemar L. Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line. J Clin Pharmacol. 2014, 54:1299-307. 10.1002\/jcph.328","journal-title":"J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.10.059","article-title":"Randomized, assessor-blind, antim\u00fcllerian hormone-stratified, dose-response trial in Japanese in\u00a0vitro fertilization\/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta","volume":"115","author":"Ishihara O","year":"2021","unstructured":"Ishihara O, Klein BM, Arce JC. Randomized, assessor-blind, antim\u00fcllerian hormone-stratified, dose-response trial in Japanese in\u00a0vitro fertilization\/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta. Fertil Steril. 2021, 115:1478-86. 10.1016\/j.fertnstert.2020.10.059","journal-title":"Fertil Steril"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in\u00a0vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Andersen AN","year":"2017","unstructured":"Andersen AN, Nelson SM, Fauser BC, Garc\u00eda-Velasco JA, Klein BM, Arce JC. Individualized versus conventional ovarian stimulation for in\u00a0vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. 2017, 107:387-96. 10.1016\/j.fertnstert.2016.10.033","journal-title":"Fertil Steril"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/354431-evaluation-of-assisted-reproductive-technology-outcomes-using-crossover-administration-of-two-recombinant-follicle-stimulating-hormones-in-the-same-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T06:12:16Z","timestamp":1749017536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/354431-evaluation-of-assisted-reproductive-technology-outcomes-using-crossover-administration-of-two-recombinant-follicle-stimulating-hormones-in-the-same-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.85312","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}